Committee Composition

Transcept in the News

12/14/09
Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)

11/23/09
Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter

  Audit Compensation Nominating and Corporate Governance
Glenn A. Oclassen      
Christopher B. Ehrlich Member of Audit Committee Member of Compensation Committee  
Thomas D. Kiley     Committee Chair for Nominating and Corporate Governance Committee
Kathleen D. LaPorte Member of Audit Committee    
Jake R. Nunn     Member of Nominating and Corporate Governance Committee
G. Kirk Raab Chairman of the Board      
Frederick J. Ruegsegger Financial Expert Committee Chair for Audit Committee    
Camille D. Samuels   Member of Compensation Committee  
Daniel K. Turner III   Committee Chair for Compensation Committee Member of Nominating and Corporate Governance Committee
John P. Walker      
Chair of the Board = Chair of the Board
Committee Chair = Chair
Committee Member = Member
Financial Expert = Financial Expert